Home › Companies › ARROWHEAD PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ARROWHEAD PHARMACEUTICALS INC.’s Form 8-K, filed March 19, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of March 14, 2024: 7 items on ARROWHEAD PHARMACEUTICALS INC.’s Form 8-K, filed March 19, 2024: 7 passed (calculated).
Notable dissent: 1 director (12.6% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ARROWHEAD PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ARROWHEAD PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed March 19, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Douglass Given | 76,397,567 | 10,968,346 | 303,938 | -- | -- | 87% | Passed (calculated) | — |
| Elect Director: Michael S. Perry | 82,446,900 | 4,911,855 | 311,096 | -- | -- | 94% | Passed (calculated) | — |
| Elect Director: Christopher Anzalone | 84,313,696 | 2,976,660 | 379,495 | -- | -- | 97% | Passed (calculated) | — |
| Elect Director: Mauro Ferrari | 81,342,884 | 6,020,799 | 306,168 | -- | -- | 93% | Passed (calculated) | — |
| Elect Director: Adeoye Olukoton | 83,526,809 | 3,815,731 | 327,311 | -- | -- | 96% | Passed (calculated) | — |
| Elect Director: William Waddill | 83,279,633 | 4,079,251 | 310,967 | -- | -- | 95% | Passed (calculated) | — |
| Elect Director: Victoria Vakiener | 83,354,988 | 3,975,617 | 339,246 | -- | -- | 95% | Passed (calculated) | — |
Source: ARROWHEAD PHARMACEUTICALS INC., Form 8-K, filed with the SEC on March 19, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
293 asset managers disclosed a vote on at least one ARROWHEAD PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ARROWHEAD PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Adeoye Olukotun
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Adeoye Olukoton”): 83,526,809 for, 3,815,731 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 42,027,042 for, 135,480 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Christopher Anzalone
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Christopher Anzalone”): 84,313,696 for, 2,976,660 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 42,153,040 for, 9,482 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Douglass Given
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Douglass Given”): 76,397,567 for, 10,968,346 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 37,110,234 for, 5,052,288 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 0 | 3,855,550 | 0 | 0 | Against |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 860,818 | 0 | 0 | Against |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,774 | 128,463 | 0 | 0 | Mixed |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mauro Ferrari
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mauro Ferrari”): 81,342,884 for, 6,020,799 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 41,577,417 for, 585,105 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 0 | 168,934 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 141,129 | 0 | 0 | Against |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael S. Perry
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael S. Perry”): 82,446,900 for, 4,911,855 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 42,028,875 for, 133,647 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Victoria Vakiener
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Victoria Vakiener”): 83,354,988 for, 3,975,617 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 41,746,322 for, 414,041 against, 40,746 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 0 | 280,720 | 0 | 0 | Against |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: William Waddill
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: William Waddill”): 83,279,633 for, 4,079,251 against, per its Form 8-K filed March 19, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 80 asset managers below reported 42,028,875 for, 133,647 against, 38,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Fund voting reports, all 79 managers: 42,105,703 for, 766 against, 38,587 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lazard | 19,000,000 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 6,983,630 | 0 | 0 | 0 | For |
| State Street | 6,622,179 | 0 | 0 | 0 | For |
| Fidelity | 6,352,116 | 0 | 0 | 0 | For |
| BlackRock | 3,916,239 | 539 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,634,955 | 0 | 0 | 0 | For |
| UBS | 1,651,047 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| Slate Path Capital LP | 1,416,991 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,287,207 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 1,184,524 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Aquilo Capital Management, LLC | 0 | 0 | 0 | 908,474 | Withhold |
| ORBIMED ADVISORS LLC | 739,651 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 624,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 481,208 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 470,038 | 0 | 0 | 0 | For |
| Citadel | 427,962 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 425,963 | 0 | 0 | 0 | For |
| Nuveen | 362,857 | 0 | 0 | 0 | For |
| Vanguard | 343,784 | 0 | 0 | 0 | For |
| EAGLE ASSET MANAGEMENT INC | 323,495 | 0 | 0 | 0 | For |
| JPMorgan | 281,292 | 0 | 0 | 0 | For |
| Invesco | 262,693 | 0 | 0 | 0 | For |
| AllianceBernstein | 225,204 | 0 | 0 | 0 | For |
Institutional-manager reports, all 237 managers: 63,076,918 for, 734,422 against, 908,474 withheld, 11 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE SELECTION OF KPMG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.
The 79 asset managers below reported 42,106,469 for, 38,587 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 373,142 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| John Hancock | 120,180 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. All 79 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 107,500,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.05% |
| 2 | BlackRock | 8.24% |
| 3 | Fidelity | 7.68% |
| 4 | State Street | 3.59% |
| 5 | Capital Group | 1.43% |
| 6 | JPMorgan | 1.32% |
| 7 | Charles Schwab | 0.90% |
| 8 | Columbia Threadneedle | 0.80% |
| 9 | Equitable | 0.42% |
| 10 | AIG/SunAmerica | 0.35% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Lazard | 17.67% |
| 2 | Avoro Capital Advisors LLC | 6.50% |
| 3 | State Street | 6.16% |
| 4 | Fidelity | 5.91% |
| 5 | BlackRock | 3.64% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.45% |
| 7 | UBS | 1.54% |
| 8 | Capital Group | 1.43% |
| 9 | Slate Path Capital LP | 1.32% |
| 10 | MELLON INVESTMENTS Corp | 1.20% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 20,224,825 | 18.81% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 16,035,870 | 14.92% | Form 13F, quarter ended March 31, 2024 |
| State Street | 6,560,703 | 6.10% | Form 13F, quarter ended March 31, 2024 |
| FMR (Fidelity) | 5,759,830 | 5.36% | Form 13F, quarter ended March 31, 2024 |
| Christopher Anzalone | 3,715,048 | 3.46% | Proxy statement (DEF 14A), proxy filed January 26, 2024 |
| Geode Capital | 2,754,634 | 2.56% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 1,823,578 | 1.70% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 1,702,674 | 1.58% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,300,649 | 1.21% | Form 13F, quarter ended March 31, 2024 |
| Norges Bank | 1,257,545 | 1.17% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 107,500,000 shares outstanding, as reported by ARROWHEAD PHARMACEUTICALS INC. on its Form 10-Q dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ARROWHEAD PHARMACEUTICALS INC.'s shareholder meeting held March 14, 2024, in the 2023-2024 proxy season, 293 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,979 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ARROWHEAD PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ARROWHEAD PHARMACEUTICALS INC.’s 10-Q dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ARROWHEAD PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “ARROWHEAD PHARMACEUTICALS (ARWR) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/arrowhead-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.